Covidien has announced the launch of the HALO90 ULTRA ablation catheter, according to a news release.
The HALO90 ULTRA is an addition to the company's HALO family of catheters for the endoscopic treatment of Barrett's esophagus. It is designed to be used independently or in conjunction with the Covidien's HALO90 and HALO60 ablation catheters, both smaller focal devices, and the HALO360+ ablation catheter, a balloon-based endoscopic ablation system for treating larger, circumferential areas of Barrett's esophagus.
"The HALO90 ULTRA is an exciting development for patients with Barrett's esophagus, as well as for those suffering from a condition commonly referred to as 'watermelon stomach,' where chronic bleeding occurs," said Vafa Jamali, vice president and general manager, Covidien GI Solutions, in the release. "We are receiving positive feedback not only from clinicians who used the device in the esophagus, but also used it to cauterize the stomach bleeding, where patients otherwise undergo repeated blood transfusions."
The HALO90 ULTRA has received the CE Mark. It is currently available in the United States and Europe.
Related Articles on Covidien:
Covidien, GE Healthcare Announce Patient Monitor Collaboration
Covidien Acquires Israeli Hernia Mesh Placement Technology Company
Amerinet Partners With Covidien for Vascular Therapy Products